Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays.
about
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularCancer across the tree of life: cooperation and cheating in multicellularityAmerican Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancerEstrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status.Budget impact analysis of a breast rapid diagnostic unit.Systematic bias in genomic classification due to contaminating non-neoplastic tissue in breast tumor samples.Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularClinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer.Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.The effect of freezing on the immunoprofile of breast carcinoma cells.In vivo magnetic resonance imaging of the estrogen receptor in an orthotopic model of human breast cancer.A dynamic clinical pathway for the treatment of patients with early breast cancer is a tool for better cancer care: implementation and prospective analysis between 2002-2010p16 expression correlates with basal-like triple-negative breast carcinomaBiospecimens and biorepositories for the community pathologist.EP1: a novel rabbit monoclonal antibody for detection of oestrogen receptor αGlut-1 Expression Correlates with Basal-like Breast Cancer.American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
P2860
Q26828860-BA5B1E6B-8500-4E55-B6D3-22FF60327B11Q27026902-DBD89371-CAEE-4135-AD19-0688113E1602Q30494798-9B535DB4-71BD-4747-8D89-A07C865EB5E0Q31097623-BC2923ED-2205-45F6-B3AF-442538C729DDQ33840191-6FECF3C5-EBAA-4406-96E7-00432627952EQ33947222-26B52503-CC35-4F08-842B-AE7E2C2D2332Q34159011-5148002E-C8E1-474F-BB68-83D1A497A15BQ34328025-85C293A7-B3A9-4733-AD07-D835168311EAQ34363206-C88730ED-3E36-49B4-86B4-5D97859953D0Q35053377-50183C8E-D888-4B97-B6DB-F426DD5E3AF0Q35624196-2D7BDE53-44A2-4930-946C-A2FE5625EE8FQ36759043-400A5E95-D6C3-4260-AADA-70A5563E7B1EQ36863171-3EB8871D-00D9-4D33-AB14-B1A5F2EEE5A3Q36920645-37A326E7-FE26-4460-A7A8-AEDC9C007AA7Q37345948-18E637F5-D0DC-45C2-86AF-B8ACB21DC53FQ39939602-8CC584DC-64FC-4B37-8DA0-C53E8906A04FQ51692190-D052384A-5812-4178-81EA-A7970D8A531F
P2860
Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recommendations for validating ...... r immunohistochemistry assays.
@en
Recommendations for validating ...... r immunohistochemistry assays.
@nl
type
label
Recommendations for validating ...... r immunohistochemistry assays.
@en
Recommendations for validating ...... r immunohistochemistry assays.
@nl
prefLabel
Recommendations for validating ...... r immunohistochemistry assays.
@en
Recommendations for validating ...... r immunohistochemistry assays.
@nl
P2093
P1476
Recommendations for validating ...... r immunohistochemistry assays.
@en
P2093
D Craig Allred
Douglas A Murphy
M Elizabeth H Hammond
Patrick L Fitzgibbons
Paul N Valenstein
P304
P356
10.1043/1543-2165-134.6.930
P577
2010-06-01T00:00:00Z